metaraminol has been researched along with Critical Illness in 4 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Critical Illness: A disease or state in which death is possible or imminent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abu Sardaneh, A | 3 |
Penm, J | 4 |
Oliver, M | 3 |
Gattas, D | 3 |
Mclachlan, A | 1 |
Patanwala, A | 1 |
McLachlan, AJ | 3 |
James, C | 1 |
Cella, C | 1 |
Aljuhani, O | 1 |
Acquisto, NM | 1 |
Patanwala, AE | 3 |
Sardaneh, AA | 1 |
Goradia, S | 1 |
Narayan, SW | 1 |
4 other studies available for metaraminol and Critical Illness
Article | Year |
---|---|
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients.
Topics: Critical Illness; Humans; Metaraminol; Norepinephrine; Retrospective Studies; Vasoconstrictor Agents | 2023 |
International pharmacy survey of peripheral vasopressor infusions in critical care (INFUSE).
Topics: Adult; Critical Care; Critical Illness; Cross-Sectional Studies; Humans; Metaraminol; Norepinephrine | 2023 |
Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospital.
Topics: Critical Illness; Humans; Metaraminol; Pharmacoepidemiology; Tertiary Care Centers; Vasoconstrictor | 2021 |
Dose equivalence between metaraminol and norepinephrine in critical care.
Topics: Adult; Aged; Critical Care; Critical Illness; Humans; Male; Metaraminol; Norepinephrine; Retrospecti | 2022 |